Alentis Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Alentis Therapeutics is a Swiss developer of treatments for organ fibrosis and CLDN1 positive tumors
Investors:
we tracked 13 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 286M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Alentis Therapeutics
Name | Criteria | |
---|---|---|
![]() |
CatalYm
63%
|
|
![]() |
InnovaFeed SAS
63%
|
|
![]() |
Memo Therapeutics
63%
|
|
![]() |
Peptomyc
63%
|
|
![]() |
Peptone
63%
|
|
![]() |
Salvia BioElectronics
63%
|
|
![]() |
Sarcura
63%
|
|
![]() |
Synendos Therapeutics
63%
|
|
![]() |
Cytoki Pharma
63%
|
|
![]() |
AMSilk
63%
|
|